Understanding why smokers relight their cigarettes

Evaluating Cigarette Relighting Behavior: Prevalence, Correlates, Toxicant Exposure, and Implications for Cessation

NIH-funded research Rutgers Biomedical and Health Sciences · NIH-11009566

This study looks at why some smokers put out their cigarettes and then light them up again later, especially focusing on those who might be struggling financially, to better understand how this habit affects their health and to find ways to help them quit smoking for good.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project IDNIH-11009566 on NIH RePORTER

What this research studies

This research investigates the behavior of smokers who extinguish and later relight their cigarettes, a practice that may be more common among certain groups, particularly those with lower socioeconomic status. It aims to understand the prevalence of this behavior, the reasons behind it, and its implications for health and smoking cessation efforts. By examining the toxicant exposure and health outcomes associated with relighting, the study seeks to inform better treatment strategies for smokers. The research will involve surveys and assessments to gather data on smoking habits and health impacts.

Who could benefit from this research

Good fit: Ideal candidates for this research are adult smokers, particularly those who frequently relight their cigarettes and may be from disenfranchised backgrounds.

Not a fit: Patients who do not smoke or those who have successfully quit smoking will not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved smoking cessation strategies and better health outcomes for smokers who engage in relighting behavior.

How similar studies have performed: While there has been research on smoking behaviors, the specific focus on cigarette relighting as a significant factor in smoking cessation is relatively novel and has not been extensively studied.

Where this research is happening

Newark, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.